Beyond 7+3: Redefining AML Treatment with Targeted Therapies and Trials

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded02 Apr 2026

Publisherfeeds.buzzsprout.com

Handlerec:17563250

Show notes

Director of the Inpatient Leukemia Unit, Anjali Advani, MD joins the Cancer Advances podcast to break down the latest acute myeloid leukemia clinical trials. From venetoclax-based regimens to emerging menin inhibitors and mutation-driven strategies, listen as Dr. Advani explains how rapid genomics, novel combinations and evolving transplant decisions are reshaping AML care and what still lies ahead for high-risk disease.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in